KRAS and familial pancreatic carcinoma: SGs function as a resistance mechanism to current chemotherapies against PDAC; therefore, interfering with their formation could provide an effective, new approach to sensitizing to chemotherapeutic agents Kras-mutated tumors, a mutation found in almost all pancreatic cancer cells.